Anti-IL-23 therapy for the treatment of moderate-to-severe inverse psoriasis: A 52-week multicentre study.
Joan CeravallsRicardo Ruiz VillaverdeSusana ArmestoJosé Manuel Fernández ArmenterosJosep Riera-MonroigTamara Gracia CazañaMònica Quintana-CodinaMaribel Iglesias-SanchoMontserrat SallerasAdrián Imbernón MoyaFrancisco Javier Melgosa RamosMarta FerranPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2024)